Cosmo Pharmaceuticals N.V.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Cosmo Pharmaceuticals N.V.'s balance sheet done over the years? Its assets were worth $553,980,000 last year, which is less than in the previous period. 23% of Cosmo Pharmaceuticals N.V.’s total assets is currently financed by debt. Its liabilities reached the amount of $124,944,000, which means an decrease by -58% compared compared to last year.
Debt to Assets
| 2014 | 225621000 | 73.33M | 32.5% |
|---|---|---|---|
| 2015 | 437943000 | 34.29M | 7.83% |
| 2016 | 443474000 | 27.91M | 6.29% |
| 2017 | 497974000 | 27.85M | 5.59% |
| 2018 | 625686000 | 180.83M | 28.9% |
| 2019 | 585160000 | 191.42M | 32.71% |
| 2020 | 596161000 | 196.03M | 32.88% |
| 2021 | 805562000 | 292.88M | 36.36% |
| 2022 | 759592000 | 295.80M | 38.94% |
| 2023 | 553980000 | 124.94M | 22.55% |
0RGI.L Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 50.27M | 185.82M | 198.56M | 185.93M | 110.38M | 210.68M | 144.94M | 117.64M | 71.27M | 34.13M |
Short term investments | 0 | 55.12M | 23.64M | 26.91M | 157.82M | 138.74M | 27.75M | 48.83M | 45.06M | 25.32M |
Net receivables | 28.45M | 38.61M | 24.45M | 26.99M | 19.07M | 0 | 13.19M | 0 | 16.80M | 4.79M |
Inventory | 14.19M | 11.49M | 13.11M | 5.70M | 6.14M | 3.93M | 3.24M | 2.30M | 2.24M | 3.32M |
Other current assets | 9.29M | 53.64M | 39.71M | 34.23M | 166.76M | 0 | 8.17M | 18.28M | 2.53M | 3.12M |
Total current assets | 102.22M | 306.09M | 275.84M | 252.86M | 302.36M | 374.16M | 197.30M | 187.07M | 137.93M | 70.70M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 28.58M | 30.27M | 30.47M | 29.30M | 30.18M | 28.61M | 30.15M | 20.67M | 21.13M | 21.44M |
Goodwill | 24.00M | 24.00M | 24.00M | 1.43M | 1.43M | 1.43M | 109K | 109K | 109K | 109K |
Intangible assets | 355.62M | 366.83M | 372.73M | 26.64M | 49.21M | 35.52M | 28.52M | 19.54M | 4.49M | 10.30M |
Long term investments | 3.28M | -46.85M | 25.43M | 223.69M | 21.63M | 33.51M | 201.79M | 164.65M | 227.15M | 95.5M |
Other non-current assets | 40.25M | 64.55M | 58.43M | 54.02M | 170.31M | 140.70M | 29.63M | 48.83M | 45.06M | 25.32M |
Total non-current assets | 451.75M | 453.49M | 529.71M | 343.29M | 282.79M | 251.51M | 300.66M | 256.4M | 300.01M | 154.91M |
Total assets | 553.98M | 759.59M | 805.56M | 596.16M | 585.16M | 625.68M | 497.97M | 443.47M | 437.94M | 225.62M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 9.30M | 0 | 5.56M | 3.49M | 1.27M | 0 | 2.38M | 3.44M | 876K | 47.42M |
Short term debt | 897K | 171.82M | 889K | 2.93M | 1.5M | 527K | 649K | 849K | 1.55M | 2M |
Total current liabilities | 25.71M | 194.94M | 21.23M | 21.79M | 15.70M | 15.34M | 19.43M | 18.71M | 25.04M | 60.65M |
| Non-current liabilities: | ||||||||||
Long term debt | 942K | 1.77M | 169.02M | 165.20M | 163.33M | 157.62M | 3.82M | 4.46M | 6.57M | 8.93M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 98.28M | 1.99M | 2.39M | 2.39M | 3.25M | 156.15M | 4.59M | 2.27M | 2.67M | 449K |
Total non-current liabilities | 99.23M | 100.85M | 271.64M | 174.24M | 175.72M | 165.48M | 8.42M | 9.19M | 9.25M | 12.67M |
Total liabilities | 124.94M | 295.80M | 292.88M | 196.03M | 191.42M | 180.83M | 27.85M | 27.91M | 34.29M | 73.33M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |